Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
61,134.70 +467.67 (+0.77%) CMC Crypto 200
1,264.60 -93.41 (-6.88%)
UTHR May 2024 185.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:50PM EDT. Market open.
| Previous close | 42.51 |
| Open | 42.51 |
| Bid | 39.30 |
| Ask | 42.50 |
| Strike | 185.00 |
| Expiry date | 2024-05-17 |
| Day's range | 42.51 - 42.51 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksInsmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
- Zacks
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Iovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for the recently-approved melanoma drug Amtagvi in the United States.
ZacksCRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
© 2024 Yahoo. All rights reserved.